JP2001513080A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513080A5
JP2001513080A5 JP1998535034A JP53503498A JP2001513080A5 JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5 JP 1998535034 A JP1998535034 A JP 1998535034A JP 53503498 A JP53503498 A JP 53503498A JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998535034A
Other languages
English (en)
Japanese (ja)
Other versions
JP4975201B2 (ja
JP2001513080A (ja
Filing date
Publication date
Priority claimed from US08/797,817 external-priority patent/US6060513A/en
Priority claimed from US08/797,820 external-priority patent/US5990166A/en
Priority claimed from US08/796,340 external-priority patent/US5939381A/en
Priority claimed from US08/796,338 external-priority patent/US5776888A/en
Priority claimed from US08/796,336 external-priority patent/US6358504B1/en
Priority claimed from US08/797,816 external-priority patent/US6090958A/en
Priority claimed from US08/796,335 external-priority patent/US5876710A/en
Priority claimed from US08/796,339 external-priority patent/US5804688A/en
Priority claimed from US08/796,334 external-priority patent/US5879681A/en
Priority claimed from US08/796,337 external-priority patent/US5773647A/en
Priority claimed from US08/797,813 external-priority patent/US6051561A/en
Priority claimed from US08/797,100 external-priority patent/US6313088B1/en
Application filed filed Critical
Priority claimed from PCT/US1998/002619 external-priority patent/WO1998034632A1/en
Publication of JP2001513080A publication Critical patent/JP2001513080A/ja
Publication of JP2001513080A5 publication Critical patent/JP2001513080A5/ja
Application granted granted Critical
Publication of JP4975201B2 publication Critical patent/JP4975201B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53503498A 1997-02-07 1998-02-06 化合物及び活性剤を送達するための組成物 Expired - Fee Related JP4975201B2 (ja)

Applications Claiming Priority (27)

Application Number Priority Date Filing Date Title
US79634197A 1997-02-07 1997-02-07
US08/797,816 US6090958A (en) 1995-03-31 1997-02-07 Compounds and compositions for delivering active agents
US08/796,335 US5876710A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,336 1997-02-07
US08/796,339 US5804688A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,100 1997-02-07
US08/796,340 1997-02-07
US08/796,337 US5773647A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,813 1997-02-07
US08/796,334 US5879681A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,817 US6060513A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,338 1997-02-07
US08/796,337 1997-02-07
US08/797,100 US6313088B1 (en) 1997-02-07 1997-02-07 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US08/797,813 US6051561A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,820 US5990166A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,336 US6358504B1 (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,341 1997-02-07
US08/796,338 US5776888A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/797,816 1997-02-07
US08/796,340 US5939381A (en) 1997-02-07 1997-02-07 Compounds and compositions for delivering active agents
US08/796,335 1997-02-07
US08/797,817 1997-02-07
US08/796,339 1997-02-07
US08/796,334 1997-02-07
US08/797,820 1997-02-07
PCT/US1998/002619 WO1998034632A1 (en) 1997-02-07 1998-02-06 Compounds and compositions for delivering active agents

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2000311231A Division JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311230A Division JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2009246865A Division JP5215977B2 (ja) 1997-02-07 2009-10-27 化合物及び活性剤を送達するための組成物

Publications (3)

Publication Number Publication Date
JP2001513080A JP2001513080A (ja) 2001-08-28
JP2001513080A5 true JP2001513080A5 (enExample) 2007-06-07
JP4975201B2 JP4975201B2 (ja) 2012-07-11

Family

ID=27584608

Family Applications (3)

Application Number Title Priority Date Filing Date
JP53503498A Expired - Fee Related JP4975201B2 (ja) 1997-02-07 1998-02-06 化合物及び活性剤を送達するための組成物
JP2000311230A Expired - Fee Related JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311231A Expired - Fee Related JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2000311230A Expired - Fee Related JP4012679B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物
JP2000311231A Expired - Fee Related JP3964613B2 (ja) 1997-02-07 2000-10-11 化合物及び活性剤を送達するための組成物

Country Status (9)

Country Link
EP (3) EP1015008B1 (enExample)
JP (3) JP4975201B2 (enExample)
AT (2) ATE383169T1 (enExample)
CA (3) CA2279331C (enExample)
DK (2) DK0993831T3 (enExample)
ES (2) ES2297909T3 (enExample)
NZ (3) NZ337131A (enExample)
PT (1) PT1093819E (enExample)
WO (1) WO1998034632A1 (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2595697A (en) 1996-03-29 1997-10-22 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU728523C (en) 1996-10-21 2001-08-09 Nps Pharmaceuticals, Inc. Neurotrophin antagonist compositions
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
IL140930A0 (en) * 1998-08-07 2002-02-10 Emisphere Tech Inc Compounds and compositions for delivering active agents
EP1676832A3 (en) * 1998-08-07 2006-09-06 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
AU3357800A (en) 1999-02-05 2000-08-25 Emisphere Technologies, Inc. Method of preparing alkylated salicylamides
NZ534409A (en) * 1999-04-05 2006-03-31 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US6492380B1 (en) 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
KR20100035666A (ko) 1999-11-23 2010-04-05 메틸진 인크. 히스톤 디아세틸라제의 억제제
JP4879433B2 (ja) 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
JP4799794B2 (ja) * 2000-03-21 2011-10-26 エミスフェアー・テクノロジーズ・インク ジカルボキシル化中間体を介してアルキル化サリチルアミドを調製する方法。
PL357678A1 (en) * 2000-04-28 2004-07-26 Sankyo Company, Limited Ppargamma modulators
WO2003057650A2 (en) * 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
NZ523017A (en) * 2000-06-29 2004-10-29 Emisphere Tech Inc Compounds and compositions for delivering active agents and preparation method thereof
WO2002015959A2 (en) * 2000-08-18 2002-02-28 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP5073153B2 (ja) 2001-06-01 2012-11-14 ノバルティス アーゲー 副甲状腺ホルモンおよびカルシトニンの経口投与
DE60233803D1 (de) * 2001-08-17 2009-11-05 Novartis Ag 5-cnac zur oralen verabreichung von parathormonfragmenten
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
WO2003035602A1 (en) * 2001-10-25 2003-05-01 Sankyo Company, Limited Lipid modulators
CA2466863A1 (en) * 2001-11-29 2003-06-05 Emisphere Technologies, Inc. Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
AU2003208945B2 (en) * 2002-02-20 2008-05-01 Emisphere Technologies, Inc Method for administering GLP-1 molecules
TW200403052A (en) * 2002-07-17 2004-03-01 Novartis Ag Use of organic compounds
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
MXPA05012278A (es) * 2003-05-14 2006-02-10 Emisphere Tech Inc Composiciones para suministrar peptido yy y combatientes pyy.
CN1802171B (zh) * 2003-06-10 2010-10-13 株式会社Lg生命科学 不包含血清白蛋白的人红细胞生成素的稳定水溶液
ES2286679T3 (es) * 2003-08-20 2007-12-01 Eli Lilly And Company Compuestos, procedimientos y formulaciones para la liberacion oral de un compuesto de peptido de tipo glucagon (glp)-1 o un peptido agonist a del receptor de melanocortina 4 (mc4).
EP1658273B1 (en) * 2003-08-20 2007-01-03 Eli Lilly And Company Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
ES2393324T3 (es) * 2004-05-14 2012-12-20 Emisphere Technologies, Inc. Compuestos y composiciones para administrar principios activos
BRPI0510906A (pt) 2004-05-19 2007-11-06 Emisphere Tech Inc composição farmacêutica tópica, composição para administração tópica e seu uso
BRPI0510820A (pt) 2004-05-19 2007-11-27 Emisphere Tech Inc composição farmacêutica, forma unitária de dosagem e seus usos
CN105708787A (zh) 2004-07-12 2016-06-29 爱密斯菲尔科技公司 用于递送肽yy和pyy激动剂的组合物
AU2005271526B2 (en) 2004-08-03 2011-12-08 Emisphere Technologies, Inc. Antidiabetic oral insulin-biguanide combination
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
MX2007008082A (es) 2004-12-29 2007-09-05 Emisphere Tech Inc Formulaciones farmaceuticas de sales de galio.
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
KR20110084339A (ko) 2005-07-09 2011-07-21 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한 헤테로아릴 벤즈아미드 유도체
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
EP2057112B1 (en) 2006-08-31 2018-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
EP2059260B1 (en) * 2006-08-31 2013-06-19 Novartis AG Pharmaceutical compositions comprising hGH for oral delivery
CN101616583A (zh) 2007-02-08 2009-12-30 爱密斯菲尔科技公司 苯烷基羧酸输送剂
US20110039930A1 (en) * 2009-08-03 2011-02-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
US20130150323A1 (en) * 2010-02-04 2013-06-13 Urigen Pharmaceuticals, Inc Use of oral heparin preparations to treat urinary tract diseases and conditions
CN104758936A (zh) * 2015-03-11 2015-07-08 苏州维泰生物技术有限公司 能输送生物活性物质的合成小分子化合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
FR2374910A1 (fr) 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4757066A (en) * 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
US4925673A (en) 1986-08-18 1990-05-15 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
JPH05239021A (ja) 1990-09-04 1993-09-17 Microbial Chem Res Found 新規なアクチノニン誘導体
HU211995B (en) * 1992-06-30 1996-01-29 Gyogyszerkutato Intezet Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them
US5643957A (en) * 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
AU2595697A (en) * 1996-03-29 1997-10-22 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents

Similar Documents

Publication Publication Date Title
JP2000509942A5 (enExample)
JP2000509912A5 (enExample)
JP2000509635A5 (enExample)
JP2000510751A5 (enExample)
JP2000509637A5 (enExample)
JP2000507042A5 (enExample)
JP2000509587A5 (enExample)
JP2002514268A5 (enExample)
JP2000507369A5 (enExample)
JP2001524242A5 (enExample)
JP2000507433A5 (enExample)
JP2001516537A5 (enExample)
JP2001512515A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2001518028A5 (enExample)
JP2000508841A5 (enExample)
JP2000508680A5 (enExample)
JP2000509804A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2000508102A5 (enExample)
JP2000509520A5 (enExample)
JP2000507434A5 (enExample)